Melanotic PEComa

医学
作者
Arnaud de la Fouchardière,David Papke,Daniel Pissaloux,Eleanor Russell‐Goldman,Franck Tirode,Christopher D.�M. Fletcher,John Hanna
出处
期刊:The American Journal of Surgical Pathology [Lippincott Williams & Wilkins]
卷期号:48 (1): 88-96 被引量:2
标识
DOI:10.1097/pas.0000000000002135
摘要

Perivascular epithelioid cell neoplasms (PEComas) are tumors of uncertain cell lineage that show a strong female predominance. Their hallmark is the presence of combined smooth muscle and melanocytic differentiation. In most cases, melanocytic differentiation is detectable only by immunohistochemistry, but there are rare reports of PEComa with extensive melanin accumulation (so-called “melanotic PEComa”). Here we report a clinicopathologic series of 7 melanotic PEComas that occurred across a wide patient age range of 21 to 82 years (median: 41 y) and with a wide anatomic distribution, including 2 cases in the pelvis and 1 case each in the gallbladder, cervix, eyelid, epidural space, and femur. All tumors were heavily pigmented and, like conventional PEComas, were composed of variably sized neoplastic cells with voluminous granular, or less commonly clear, cytoplasm with prominent nucleoli. All tumors expressed HMB45 by immunohistochemistry, and 6 of 7 showed nuclear TFE3 expression. Where tested, tumors were uniformly negative for Mart-1/Melan-A, S100, desmin, and smooth muscle actin. Molecular analysis identified TFE3 gene rearrangement in 5 of 7 cases, 4 of which were demonstrated by fluorescence in situ hybridization and one by whole-exome RNA sequencing which revealed a SFPQ :: TFE3 fusion. The one tumor negative for TFE3 by immunohistochemistry was found instead to harbor a SFPQ :: TFEB fusion, the first reported example to our knowledge of TFEB fusion in a PEComa. Clinical follow-up was available for 6 of 7 patients (median: 2.5 y: range: 0.75 to 7 y). The patient whose tumor harbored SFPQ :: TFEB died of metastatic disease 9 months after diagnosis. The other tumors behaved in an indolent fashion: 4 patients were alive without evidence of disease at the most recent follow-up and 1 patient died of an unrelated cancer 4 years after diagnosis of the melanotic PEComa. Our results expand the morphologic and molecular spectrum of melanotic PEComa, and awareness of this rare but distinctive subtype is important to ensure accurate diagnosis within the broader family of heavily pigmented neoplasms.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
默默然完成签到 ,获得积分10
2秒前
净心完成签到,获得积分10
3秒前
Driscoll完成签到 ,获得积分10
7秒前
m李完成签到 ,获得积分10
10秒前
围城完成签到 ,获得积分10
15秒前
15秒前
SAY完成签到 ,获得积分10
20秒前
crazy完成签到 ,获得积分10
21秒前
Trost完成签到,获得积分10
22秒前
苹果万恶完成签到 ,获得积分20
29秒前
jinjing完成签到,获得积分10
32秒前
酷波er应助mrli采纳,获得10
35秒前
春春完成签到,获得积分10
44秒前
46秒前
快乐的千兰完成签到 ,获得积分10
49秒前
ABO发布了新的文献求助10
49秒前
就很棒的小俊完成签到 ,获得积分10
49秒前
紫色水晶之恋应助Lny采纳,获得10
52秒前
mrli发布了新的文献求助10
53秒前
Do神完成签到,获得积分10
56秒前
图喵喵完成签到,获得积分10
1分钟前
MRJJJJ完成签到,获得积分0
1分钟前
平常以云完成签到 ,获得积分10
1分钟前
Song完成签到 ,获得积分10
1分钟前
锂电说完成签到 ,获得积分10
1分钟前
害羞孤风完成签到 ,获得积分10
1分钟前
王kk完成签到 ,获得积分10
1分钟前
刘刘刘完成签到 ,获得积分10
1分钟前
化学民工完成签到 ,获得积分10
1分钟前
LHL完成签到,获得积分10
1分钟前
1分钟前
vkk完成签到 ,获得积分10
1分钟前
mushiyu完成签到 ,获得积分10
1分钟前
香锅不要辣完成签到 ,获得积分10
1分钟前
大大怪将军应助好晒采纳,获得10
1分钟前
Mushiyu完成签到 ,获得积分10
1分钟前
whitepiece完成签到,获得积分0
1分钟前
1分钟前
1分钟前
xcz完成签到 ,获得积分10
1分钟前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Development of a Bridge Weigh-In-Motion System: A technology to convert the bridge response to the passage of traffic into data on vehicle configurations, speeds, times of travel and weights 1000
ズームレンズの光学設計に関する研究 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Matrix Methods in Data Mining and Pattern Recognition Second Edition 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7282356
求助须知:如何正确求助?哪些是违规求助? 8903141
关于积分的说明 18833851
捐赠科研通 6953259
什么是DOI,文献DOI怎么找? 3207556
关于科研通互助平台的介绍 2377841
邀请新用户注册赠送积分活动 2182729